FDA Greenlights Osteoporosis Drug for Postmenopausal Women
U.S. FDA Chief Gottlieb Resigns
Upadacitinib at the FDA
Canada Approves Erelzi for PsA; Plus FDA Moves to Increase Access to Naloxone
FDA Advisory Committee Votes in Favor of Romosozumab Approval
FDA Update: Priority Review for Non-Opioid Treatment & New Warning for Fluoroquinolones
FDA Approves Rituximab Biosimilar; Plus New Safety Data for Filgotinib in RA Patients
FDA Update: Topical Plaque Psoriasis Treatment Approved; Dupilumab Will Receive FDA Priority Review
Rituximab Receives Label Update for ANCA-Associated Vasculitis
- 1
- 2
- 3
- …
- 22
- Next Page »